Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-04-27 12:11 pm Purchase | 13G | BioAtla, Inc. BCAB | ACORN BIOVENTURES L.P. | 2,726,455 5.7% | 2,726,455![]() (New Position) | View |
2023-02-27 4:14 pm Purchase | 13G | BioAtla, Inc. BCAB | SHORT JAY M PHD | 2,982,036 6.4% | 280,709![]() (+10.39%) | View |
2023-02-14 4:00 pm Purchase | 13G | BioAtla, Inc. BCAB | TANG CAPITAL PARTNERS LP | 3,124,076 8.6% | 835,176![]() (+36.49%) | View |
2023-02-14 3:10 pm Purchase | 13G | BioAtla, Inc. BCAB | Cormorant Asset Management LP | 3,680,365 7.98% | 1,642,150![]() (+80.57%) | View |
2023-02-09 11:12 am Sale | 13G | BioAtla, Inc. BCAB | VANGUARD GROUP INC | 1,931,039 4.19% | -333,615![]() (-14.73%) | View |
2023-02-06 2:49 pm Sale | 13G | BioAtla, Inc. BCAB | WELLINGTON MANAGEMENT GROUP LLP | 1,102 0% | -3,231,378![]() (-99.97%) | View |
2023-01-09 5:00 pm Purchase | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I L.P. | 4,220,397 9.2% | 1,972,873![]() (+87.78%) | View |
2022-06-10 11:04 am Sale | 13G | BioAtla, Inc. BCAB | FMR LLC | 315,211 0.877% | -3,605,461![]() (-91.96%) | View |
2022-04-28 4:00 pm Purchase | 13G | BioAtla, Inc. BCAB | TANG CAPITAL PARTNERS LP | 2,288,900 6.4% | 2,288,900![]() (New Position) | View |
2022-02-14 4:11 pm Purchase | 13G | BioAtla, Inc. BCAB | SHORT JAY M PHD | 2,701,327 7.54% | 2,701,327![]() (New Position) | View |
2022-02-14 3:07 pm Sale | 13G | BioAtla, Inc. BCAB | Cormorant Asset Management LP | 2,038,215 5.77% | -253,845![]() (-11.07%) | View |
2022-02-11 4:55 pm Sale | 13G | BioAtla, Inc. BCAB | PFIZER INC PFE | 1,372,052 3.88% | -866,038![]() (-38.70%) | View |
2022-02-11 4:04 pm Sale | 13G | BioAtla, Inc. BCAB | HBM Healthcare Investments (Cayman) Ltd. | 1,427,317 4% | -1,263,552![]() (-46.96%) | View |
2022-02-09 3:33 pm Purchase | 13G | BioAtla, Inc. BCAB | VANGUARD GROUP INC | 2,264,654 6.41% | 2,264,654![]() (New Position) | View |
2022-02-09 09:09 am Sale | 13G | BioAtla, Inc. BCAB | FMR LLC | 3,920,672 11.092% | -156,919![]() (-3.85%) | View |
2022-02-08 11:52 am Unchanged | 13G | BioAtla, Inc. BCAB | FARALLON CAPITAL MANAGEMENT LLC | 0 0% | 0 (Unchanged) | View |
2022-02-04 09:15 am Purchase | 13G | BioAtla, Inc. BCAB | WELLINGTON MANAGEMENT GROUP LLP | 3,232,480 9.15% | 3,232,480![]() (New Position) | View |
2021-09-03 5:16 pm Sale | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I L.P. | 2,247,524 6.95% | -546,709![]() (-19.57%) | View |
2021-06-28 4:32 pm Sale | 13D | BioAtla, Inc. BCAB | Soleus Private Equity Fund I L.P. | 2,794,233 8.69% | -400,000![]() (-12.52%) | View |
2021-04-12 1:05 pm Purchase | 13G | BioAtla, Inc. BCAB | FMR LLC | 4,077,591 12.674% | 2,297,505![]() (+129.07%) | View |